Oral Quercetin in Adult Patients as a Potential Nutraceutical against Coronavirus Disease 2019 (COVID-19)
Juan Fernando Ibarra Aguilar, Gabriela Ariane Sanabria Báez, Fernando Galeano
Journal of Advances in Medical and Pharmaceutical Sciences, doi:10.9734/jamps/2021/v23i330222
Aim: To establishing the use of oral Quercetin as a potential nutraceutical against Coronavirus Disease 2019. Methods: A descriptive, prospective longitudinal study was carried out on 52 patients treated at the ECOMED-LAMB Clinic, in the period from the onset of Covid-19 in our country, March 3, 2020 to January 2021. Results: Were studied 52 patients COVID-19 positive, 20 (38.4%) were in preventive treatment and 32 patients (61.5%) was administered biological therapy once the diagnosis, no difference was found between female or male sex and the predominant age was those over 60 years. Twenty-four patients (70.6%) have presented at least one comorbidity.
Original Research Article The association of hospitalization with preventive treatment was not significant (p=0.166), we observed difference in the evolution of the patients (p= 0.084). Conclusions: Quercetin could prevent and decrease the duration of SARSCoV plausible to propose the prophylactic use of this flavonoid in order to achieve clinical benefits.
COMPETING INTERESTS Authors have declared that no competing interests exist.
References
Andersen, Weber, Wood, Hughes, Murray et al., In-vitro virucidal activity of selected anthraquinones and anthraquinone derivatives, Antiviral Research
Badawi, Ryoo, Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis, International Journal of Infection Disease,
doi:10.1016/j.ijid.2016.06.015Biancatelli, Berrill, Catravas, Marik, Quercetin and vitamin C: An experimental, synergistic therapy for the prevention and treatment of SARSCoV-2 related disease (COVID-19), Frontiers in Immunology,
doi:10.3389/fimmu.2020.01451Booth, Matukas, Tomlinson, Rachlis, Rose et al., Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area, Journal of the American Medical Association,
doi:10.1001/jama.289.21.JOC30885Chen, Liu, Liu, Liu, Xu et al., A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19
Furuya, Uozaki, Yamasaki, Arakawa, Aritakoyama, Antiviral effects of ascorbic and dehydroascorbic acids in-vitro, International Journal of Molecular Medicine,
doi:10.3892/ijmm_00000053Gonzalez, Fontanes, Raychaudhuri, Loo, Loo et al., The heat shock protein inhibitor Quercetin attenuates hepatitis C virus production, Hepatology
Harwood, Danielewska-Nikiel, Borzelleca, Flamm, Williams et al., A critical review of the data related to the safety of quercetin and lack of evidence in vivo toxicity, including lack of genotoxic/carcinogenic properties, Food and Chemical Toxicology
Keller, Inventor, None
Kim, Jeon, Ko, Flavanone glycosides from Citrus junos and their antiinfluenza virus activity, Planta Medica
Li, Yao, Han, Yang, Chaudhry et al., Quercetin, inflammation and immunity, Nutrients,
doi:10.3390/nu8030167Moreira, Lima, Da Cruz, Quercetin as a potential nutraceutic against coronavirus disease 2019 (COVID-19), Ars Pharmaceutica,
doi:10.30827/ars.v62i1.15684Mrityunjaya, Pavithra, Neelam, Janhavi, Halami et al., Immune-boosting, antioxidant and antiinflammatory food supplements targeting pathogenesis of COVID-19
Olthof, Hollman, Vree, Katan, Bioavalabilities of quercetin-3-glucoside anda quercetin-4'-glucoside do not differ in humans, The Journal of Nutrition
Palamar, Gruzeva, The estimation of economic effectiveness of preventive measures of non-infectious diseases, Wiadomosci Lekarskie
Phoenix Biosciences, Assignee, Treatments for viral infections, United States Patent US
Semple, Pyke, Reynolds, Flower, In-vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus, Antiviral Res
Smith, Smith, Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARSCoV-2 viral spike protein and viral spike protein-human ACE2 interface, Chem Rxiv,
doi:10.26434/chemrxiv.11871402Wu, Li, Li, He, Jiang et al., Quercetin as an antiviral agent inhibits Influenza A Virus (IAV) entry, Viruses,
doi:10.3390/v8010006Yi, Li, Yuan, Qu, Chen et al., Small molecules block ingtheentry of severe acute respiratory syndrome coronavirus into host cells, Journal of Virology
Yi, Li, Yuan, Qu, Chen et al., Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells, Journal of Virology,
doi:10.1128/JVI.78.20.11334-11339.2004Zhou, Yu, Du, Fan, Liu et al., Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: A retrospective cohort study, The Lancet,
doi:10.1016/S0140-6736(20)30566-3DOI record:
{
"DOI": "10.9734/jamps/2021/v23i330222",
"ISSN": [
"2394-1111"
],
"URL": "http://dx.doi.org/10.9734/jamps/2021/v23i330222",
"abstract": "<jats:p>Aim: To establishing the use of oral Quercetin as a potential nutraceutical against Coronavirus Disease 2019.
\nMethods: A descriptive, prospective longitudinal study was carried out on 52 patients treated at the ECOMED-LAMB Clinic, in the period from the onset of Covid-19 in our country, March 3, 2020 to January 2021.
\nResults: Were studied 52 patients COVID-19 positive, 20 (38.4%) were in preventive treatment and 32 patients (61.5%) was administered biological therapy once the diagnosis, no difference was found between female or male sex and the predominant age was those over 60 years. Twenty-four patients (70.6%) have presented at least one comorbidity.
\nThe association of hospitalization with preventive treatment was not significant (p=0.166), we observed difference in the evolution of the patients (p= 0.084).
\nConclusions: Quercetin could prevent and decrease the duration of SARSCoV-2 infections, it is plausible to propose the prophylactic use of this flavonoid in order to achieve clinical benefits.</jats:p>",
"author": [
{
"affiliation": [],
"family": "Aguilar",
"given": "Juan Fernando Ibarra",
"sequence": "first"
},
{
"affiliation": [],
"family": "Báez",
"given": "Gabriela Ariane Sanabria",
"sequence": "first"
},
{
"affiliation": [],
"family": "Galeano",
"given": "Fernando",
"sequence": "first"
}
],
"container-title": "Journal of Advances in Medical and Pharmaceutical Sciences",
"container-title-short": "JAMPS",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2021,
4,
11
]
],
"date-time": "2021-04-11T06:39:11Z",
"timestamp": 1618123151000
},
"deposited": {
"date-parts": [
[
2022,
9,
19
]
],
"date-time": "2022-09-19T09:58:23Z",
"timestamp": 1663581503000
},
"indexed": {
"date-parts": [
[
2022,
9,
20
]
],
"date-time": "2022-09-20T05:15:10Z",
"timestamp": 1663650910574
},
"is-referenced-by-count": 0,
"issued": {
"date-parts": [
[
2021,
4,
8
]
]
},
"link": [
{
"URL": "https://www.journaljamps.com/index.php/JAMPS/article/download/30222/56707",
"content-type": "application/pdf",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://www.journaljamps.com/index.php/JAMPS/article/download/30222/56709",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://www.journaljamps.com/index.php/JAMPS/article/download/30222/56707",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "4694",
"original-title": [],
"page": "1-7",
"prefix": "10.9734",
"published": {
"date-parts": [
[
2021,
4,
8
]
]
},
"published-online": {
"date-parts": [
[
2021,
4,
8
]
]
},
"publisher": "Sciencedomain International",
"reference-count": 0,
"references-count": 0,
"relation": {},
"resource": {
"primary": {
"URL": "https://journaljamps.com/index.php/JAMPS/article/view/488"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Oral Quercetin in Adult Patients as a Potential Nutraceutical against Coronavirus Disease 2019 (COVID-19)",
"type": "journal-article"
}
